Literature DB >> 33009248

Societal issues and policy implications related to the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.

Simon Haroutounian1,2, Ian Gilron3,4,5, Joletta Belton6,7, Louisa Degenhardt8, Marta Di Forti9,10,11, David P Finn12, Alexandra Fogarty13, Eija Kalso14,15, Elliot Krane16, R Andrew Moore17, Michael Rowbotham18, Mark Wallace19, Andrew S C Rice20.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33009248     DOI： 10.1097/j.pain.0000000000002001

Source DB:  PubMed          Journal:  Pain        ISSN： 0304-3959            Impact factor:   6.961


× No keyword cloud information.
  2 in total

Review 1.  Mass Spectrometry-Based Metabolomics of Phytocannabinoids from Non-Cannabis Plant Origins.

Authors:  Sarana Rose Sommano; Piyachat Sunanta; Noppol Leksawasdi; Kittisak Jantanasakulwong; Pornchai Rachtanapun; Phisit Seesuriyachan; Yuthana Phimolsiripol; Korawan Sringarm; Warintorn Ruksiriwanich; Pensak Jantrawut; Chuda Chittasupho
Journal:  Molecules       Date:  2022-05-20       Impact factor: 4.927

2.  International Association for the Study of Pain Presidential Task Force on Cannabis and Cannabinoid Analgesia: research agenda on the use of cannabinoids, cannabis, and cannabis-based medicines for pain management.

Authors:  Simon Haroutounian; Lars Arendt-Nielsen; Joletta Belton; Fiona M Blyth; Louisa Degenhardt; Marta Di Forti; Christopher Eccleston; David P Finn; Nanna B Finnerup; Emma Fisher; Alexandra E Fogarty; Ian Gilron; Andrea G Hohmann; Eija Kalso; Elliot Krane; Mohammed Mohiuddin; R Andrew Moore; Michael Rowbotham; Nadia Soliman; Mark Wallace; Nantthasorn Zinboonyahgoon; Andrew S C Rice
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.